Surgical treatment of malignant pleural mesothelioma. Experience in the interdisciplinary approach in Slovenia

Radiology and Oncology

Volumn 39, Issue 2, 2005, Pages

  Eržen, Janez ^a   Vidmar, Stanko ^a   Sok, Miha ^a   Debeljak, Andrej ^b   Kecelj, Peter ^b   Kovač, Viljem ^c   Stanovnik, Marjeta ^c   Rott, Tomaž ^d   Kern, Izidor ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^c INSTITUTE OF ONCOLOGY   (Slovenia)

^d INSTITUTE OF PATHOLOGY   (Slovenia)

Author keywords

Mesothelioma surgery drug therapy radiotherapy; Pleural neoplasms

Indexed keywords

CISPLATIN; GEMCITABINE; MITOMYCIN C;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG RESECTION; MALE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PLEURA MESOTHELIOMA; PLEURECTOMY; SLOVENIA; SURVIVAL RATE; THORACOTOMY;

EID: 22644437039     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996; 9: 1932-42.
2. Pass HI, Donington JS, Wu P, Rizzo P, Nishimura M, Kennedy R, et al. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J Thorac Cardiovasc Surg 1998; 116: 854-9.
3. nd edition. New York: Churchill Livingstone; 2002. p. 1241-63.
4. Roberts JR. Surgical treatment of mesothelioma: pleurectomy. Chest 1999; 116: 446S-9S.
5. Sugarbaker DJ, Garcia JP. Multimodality therapy for malignant pleural mesothelioma. Chest 1997; 112: 272S-5S.
6. Boutin C, Rey F, Viallat RJ. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 1995; 108: 754-8.
7. Ruth S, Baas P, Zoetmulder FA. Surgical treatment of malignant pleural mesothelioma. A review. Chest 2003; 123: 551-61.
8. Zellos L, Sugarbaker DJ. Current surgical management of malignant pleural mesothelioma. Curr Oncol Rep 2002; 4: 354-60.
9. Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 2000; 6: 267-74.
10. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. Thorac Cardiovasc Surg 2001; 122: 788-95.
11. Mattson K, Holsti LR, Tammilehto L, Maasilta P, Pyrhonen S, Mantyla M, et al. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 1992; 24: 643-50.
12. Huncharek M, Kelsey K, Mark EJ, Muscat J, Choi N, Carey R, et al. Treatment and survival in diffuse malignant pleural mesothelioma: a study of 83 cases from the Massachusetts General Hospital. Anticancer Res 1996; 16: 1265-8.
13. Hasturk S, Tastepe I, Unlu M, Cetin G, Baris YI. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients. J Chemother 1996, 8: 159-64.
14. Rusch V, Saltz L, Venkatraman E, Ginsberg R, McCormack P, Burt M, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994, 12: 1156-63.
15. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995; 60: 262-7.
16. Colleoni M, Sartori F, Calabro F, Nelli P, Vicario G, Sgarbossa G, et al. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 1996; 82: 53-6.
17. Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997; 4: 628-33.
18. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DL, et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1998; 66. 1128-33.
19. Kaiser LR. New therapies in treatment of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 1997; 9: 383-90.
20. Soysal O, Karaoglanoglu N, Demiracan S, Topcu S, Tastepe I, Kaya S, et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 1997; 11: 210-3.
21. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999; 68: 1799-804.
22. Grondin SC, Sugarbaker DJ. Pleuropneumonectomy in the treatment of malignant pleural mesothelioma. Chest 1999; 116: 450-4.
23. Krajevni leksikon Slovenije. Ljubljana: DZS; 1995. p. 182.
24. Debeljak A, Kecelj P, Kern I, Eržen J, Kovač V, Rott T. Medical thorascopy in pleural malignant mesothelioma. In: Zaltloukal P, Petruželka L, editors. Lung Cancer. Current Topics. Prague: Monduzzi Editore; 2001. p. 81-6.
25. Debevec M, Kovač V, Debeljak A, Eržen J, Remškar Z, Kern I. Maligni plevralni mezoteliom. Analiza bolnikov v Sloveniji 1980-1997. Zdrav Vestn 2000; 69: 599-606.
26. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiotorac Surg 2002; 22: 298-305.
27. Baldini EH, Recht A, Strauss GM, DeCamp MM Jr, Swanson SJ, Liptay MJ, et al. Patterns of failure After trimodality therapy for malignant pleural mesothelioma. Annal Thorac Surg 1997; 63: 334-8.
28. Debeljak A, Kecelj P, Kern I, Triller N, Remškar Z, Eržen J, et al. Diagnoza malignega plevralnega mezotelioma. In: Debeljak A, Turel M, editors. Simpozij bolezni plevre in simpozij presaditev pljuč. Nova Gorica, 2.-3. april 2004. Celje: Združenje pneumologov Slovenije, 2004. p. 27-34.
29. Lee Kindler H. Systemic therapy for mesothelioma: old and new. Lung Cancer 2003; 41(Suppl 3): S54.
30. Nowak AK, Byrne MJ, Williamson R, Ryan G, Segal A, Fielding D, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002; 87: 491-6.
31. Kovac V, Zwitter M, Smrdel U, Debeljak A, Cesar R. Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I - II trial. In: Jassem J, editor. Gdansk: Medimond S.r.l., Monduzzi Editore; 2004. p. 131-4.
32. Ahamad A, Stevens CW, Smythe WR, Liao Z, Vaporciyan AA, Rice D, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 2003; 9: 476-84.
33. Baldini EH. External beam radiation therapy for the treatment of pleural mesothelioma. Thorac Surg Clin 2004; 14: 543-8.
34. DaValle MJ, Faber LP, Kittle CF, Jensik RJ. Extrapleural pneumonectomy for diffuse malignant mesothelioma. Ann Thorac Surg 1986; 42: 612-8.
35. nd EACTS/ESTS Joint Meeting, Vienna, Austria 12-15 October 2003.